News and Trends 6 Nov 2019
UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
…the dark matter of the genome for novel cancer targets,” stated Kevin Pojasek, CEO of Ervaxx. Ervaxx’s initial cancer vaccines will target viral genes leftover in the genome from ancient…